Re: Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer

Klümper N, Vera-Badillo FE, Eckstein M, Hadaschik B, Grünwald V (2024)

Publication Type: Journal article

Publication year: 2024

Journal

European Urology Elsevier

DOI: 10.1016/j.eururo.2024.03.029

Authors with CRIS profile

Markus Eckstein Institute of Pathology

Involved external institutions

Universitätsklinikum Bonn DE Germany (DE) Queen's University CA Canada (CA) Universitätsklinikum Essen DE Germany (DE)

How to cite

APA:

Klümper, N., Vera-Badillo, F.E., Eckstein, M., Hadaschik, B., & Grünwald, V. (2024). Re: Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer. European Urology. https://doi.org/10.1016/j.eururo.2024.03.029

MLA:

Klümper, Niklas, et al. "Re: Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer." European Urology (2024).

BibTeX: Download